Willi Cawello - Concepedia

Author

Willi Cawello

UCB Pharma (Germany)ORCID

Also Known As

W Cawello, W. Cawello, Willi Cawello

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Germany)UCB Pharma (Belgium)Heinrich Heine University Düsseldorf Rohde & Schwarz (Germany)

About

Willi Cawello is an author at UCB Pharma (Germany) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	22	659
2	Health Sciences	3	3	84
3	Endocrinology	3	3	93
4	Biochemistry	1	1	15
5	Biomedical Engineering	1	1	33

Willi Cawello

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies Jan‐Peer Elshoff, Marina Braun, Jens‐Otto Andreas, Clinical Therapeutics Pharmaceutical ScienceIntegrated AnalysisMedicineMultiple Dose StudiesTransdermal Rotigotine	2012	108
Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine Marek Malík, J-O Andreas, Katerina Hnatkova, Clinical Pharmacology & Therapeutics	2008	79
No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers Willi Cawello, Brunhild Nickel, Andrea Eggert‐Formella The Journal of Clinical Pharmacology Therapeutic Drug MonitoringLacosamide PharmacokineticsHealthy VolunteersPharmacologyCarbamazepine Pharmacokinetics	2009	74
Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects Willi Cawello, Horst Schweer, R. M�ller, European Journal of Clinical Pharmacology Intravenous InfusionMedicinePhysiologyProstaglandin E1Clinical Pharmacology	1994	59
Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers Willi Cawello, Bernd Rosenkranz, Hans Bernhard Schmid, Epilepsia	2013	54
Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment Willi Cawello, Hilmar Bökens, Brunhild Nickel, Epilepsia	2012	52
Absorption, Disposition, Metabolic Fate, and Elimination of the Dopamine Agonist Rotigotine in Man: Administration by Intravenous Infusion or Transdermal Delivery Willi Cawello, Marina Braun, Hilmar Boekens Drug Metabolism and Disposition	2009	51
No Pharmacokinetic Interaction Between Lacosamide and Valproic Acid in Healthy Volunteers Willi Cawello, Rainer Bonn The Journal of Clinical Pharmacology Valproic AcidPharmacological StudyLacosamide PharmacokineticsValproic Acid PharmacokineticsHealthy Volunteers	2011	51
Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration Willi Cawello, Hilmar Boekens, Rainer Bonn European Journal of Drug Metabolism and Pharmacokinetics Anti-epileptic Drug LacosamidePharmacological StudyMedicineMass BalanceNeuropharmacology	2012	50
Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide Willi Cawello, Uwe Fuhr, Ursula Hering, Clinical Pharmacokinetics UrologyRenal FunctionPharmacological StudyMedicineChronic Kidney Disease	2013	40

Page 1